Loading...

Yuichiro Tanaka, PhD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentUrology
Address4150 Clement St
San Francisco CA 94121
Phone415-750-2031
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kato T, Hashimoto Y, Wong RK, Mitsui Y, Maekawa S, Chang I, Shahryari V, Yamamura S, Majid S, Saini S, Tabatabai ZL, Dahiya R, Deguchi T, Tanaka Y. Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer. J Cell Mol Med. 2018 Aug 22. PMID: 30133114.
      View in: PubMed
    2. Kulkarni P, Dasgupta P, Bhat NS, Shahryari V, Shiina M, Hashimoto Y, Majid S, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression. Mol Cancer Res. 2018 Jul 23. PMID: 30037856.
      View in: PubMed
    3. Dasgupta P, Kulkarni P, Majid S, Varahram S, Hashimoto Y, Bhat NS, Shiina M, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R. MicroRNA-203 inhibits long noncoding RNA HOTAIR and regulates tumorigenesis through epithelial-to-mesenchymal transition pathway in renal cell carcinoma. Mol Cancer Ther. 2018 Feb 13. PMID: 29440295.
      View in: PubMed
    4. Bhagirath D, Yang TL, Bucay N, Sekhon K, Majid S, Shahryari V, Dahiya R, Tanaka Y, Saini S. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer. Cancer Res. 2018 Apr 01; 78(7):1833-1844. PMID: 29437039.
      View in: PubMed
    5. Tanaka Y, Sakata Y, Hara M, Kawakubo H, Tsuruoka N, Yamamoto K, Itoh Y, Hidaka H, Shimoda R, Iwakiri R, Fujimoto K. Risk Factors for Helicobacter pylori Infection and Endoscopic Reflux Esophagitis in Healthy Young Japanese Volunteers. Intern Med. 2017 Nov 15; 56(22):2979-2983. PMID: 28943553.
      View in: PubMed
    6. Imai-Sumida M, Chiyomaru T, Majid S, Saini S, Nip H, Dahiya R, Tanaka Y, Yamamura S. Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways. Oncotarget. 2017 Nov 03; 8(54):92032-92042. PMID: 29190895.
      View in: PubMed
    7. Yamamura S, Imai-Sumida M, Tanaka Y, Dahiya R. Interaction and cross-talk between non-coding RNAs. Cell Mol Life Sci. 2018 Feb; 75(3):467-484. PMID: 28840253.
      View in: PubMed
    8. Bhat NS, Colden M, Dar AA, Saini S, Arora P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S, Dahiya R. MicroRNA-720 Regulates E-cadherin-aE-catenin Complex and Promotes Renal Cell Carcinoma. Mol Cancer Ther. 2017 Dec; 16(12):2840-2848. PMID: 28802251.
      View in: PubMed
    9. Ito Y, Sakata Y, Yoshida H, Nonaka S, Fujii S, Tanaka Y, Shirai S, Takeshita E, Akutagawa T, Kawakubo H, Yamamoto K, Tsuruoka N, Shimoda R, Iwakiri R, Fujimoto K. High Cost of Hospitalization for Colonic Diverticular Bleeding Depended on Repeated Bleeding and Blood Transfusion: Analysis with Diagnosis Procedure Combination Data in Japan. Digestion. 2017; 96(2):76-80. PMID: 28723691.
      View in: PubMed
    10. Chang I, Mitsui Y, Kim SK, Sun JS, Jeon HS, Kang JY, Kang NJ, Fukuhara S, Gill A, Shahryari V, Tabatabai ZL, Greene KL, Dahiya R, Shin DM, Tanaka Y. Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation. Oncotarget. 2017 Jun 13; 8(24):39087-39100. PMID: 28388569.
      View in: PubMed
    11. Bucay N, Bhagirath D, Sekhon K, Yang T, Fukuhara S, Majid S, Shahryari V, Tabatabai Z, Greene KL, Hashimoto Y, Shiina M, Yamamura S, Tanaka Y, Deng G, Dahiya R, Saini S. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition. Cell Death Differ. 2017 07; 24(7):1263-1274. PMID: 28498363.
      View in: PubMed
    12. Hashimoto Y, Shiina M, Kato T, Yamamura S, Tanaka Y, Majid S, Saini S, Shahryari V, Kulkarni P, Dasgupta P, Mitsui Y, Sumida M, Deng G, Tabatabai L, Kumar D, Dahiya R. The role of miR-24 as a race related genetic factor in prostate cancer. Oncotarget. 2017 Mar 07; 8(10):16581-16593. PMID: 28157714.
      View in: PubMed
    13. Mitsui Y, Shiina H, Kato T, Maekawa S, Hashimoto Y, Shiina M, Imai-Sumida M, Kulkarni P, Dasgupta P, Wong RK, Hiraki M, Arichi N, Fukuhara S, Yamamura S, Majid S, Saini S, Deng G, Dahiya R, Nakajima K, Tanaka Y. Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma. Mol Cancer Res. 2017 Jul; 15(7):884-895. PMID: 28242813.
      View in: PubMed
    14. Shiina M, Hashimoto Y, Kato T, Yamamura S, Tanaka Y, Majid S, Saini S, Varahram S, Kulkarni P, Dasgupta P, Mitsui Y, Sumida M, Tabatabai L, Deng G, Kumar D, Dahiya R. Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians. Oncotarget. 2017 Jan 31; 8(5):8356-8368. PMID: 28039468.
      View in: PubMed
    15. Colden M, Dar AA, Saini S, Dahiya PV, Shahryari V, Yamamura S, Tanaka Y, Stein G, Dahiya R, Majid S. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Cell Death Dis. 2017 01 26; 8(1):e2572. PMID: 28125091.
      View in: PubMed
    16. Sase T, Arito M, Onodera H, Omoteyama K, Kurokawa MS, Kagami Y, Ishigami A, Tanaka Y, Kato T. Hypoxia-induced production of peptidylarginine deiminases and citrullinated proteins in malignant glioma cells. Biochem Biophys Res Commun. 2017 Jan 01; 482(1):50-56. PMID: 27818200.
      View in: PubMed
    17. Bucay N, Sekhon K, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, Greene K, Tanaka Y, Dahiya R, Deng G, Saini S. Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer. Oncotarget. 2016 Oct 25; 7(43):70388-70403. PMID: 27611943.
      View in: PubMed
    18. Nip H, Dar AA, Saini S, Colden M, Varahram S, Chowdhary H, Yamamura S, Mitsui Y, Tanaka Y, Kato T, Hashimoto Y, Shiina M, Kulkarni P, Dasgupta P, Imai-Sumida M, Tabatabai ZL, Greene K, Deng G, Dahiya R, Majid S. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer. Oncotarget. 2016 Oct 18; 7(42):68371-68384. PMID: 27634912.
      View in: PubMed
    19. Shahryari V, Nip H, Saini S, Dar AA, Yamamura S, Mitsui Y, Colden M, Bucay N, Tabatabai LZ, Greene K, Deng G, Tanaka Y, Dahiya R, Majid S. Pre-clinical Orthotopic Murine Model of Human Prostate Cancer. J Vis Exp. 2016 Aug 29; (114). PMID: 27684100.
      View in: PubMed
    20. Mitsui Y, Chang I, Kato T, Hashimoto Y, Yamamura S, Fukuhara S, Wong DK, Shiina M, Imai-Sumida M, Majid S, Saini S, Shiina H, Nakajima K, Deng G, Dahiya R, Tanaka Y. Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer. Oncotarget. 2016 Aug 02; 7(31):49107-49121. PMID: 27203547.
      View in: PubMed
    21. Ogiwara T, Goto T, Aoyama T, Hara Y, Nagm A, Tanaka Y, Hongo K. Relationship Between Muscle Dissection Method and Postoperative Muscle Atrophy in the Lateral Suboccipital Approach to Vestibular Schwannoma Surgery. World Neurosurg. 2016 Oct; 94:426-431. PMID: 27450979.
      View in: PubMed
    22. Kawakubo H, Tanaka Y, Tsuruoka N, Hara M, Yamamoto K, Hidaka H, Sakata Y, Shimoda R, Iwakiri R, Kusano M, Fujimoto K. Upper Gastrointestinal Symptoms Are More Frequent in Female than Male Young Healthy Japanese Volunteers as Evaluated by Questionnaire. J Neurogastroenterol Motil. 2016 Apr 30; 22(2):248-53. PMID: 26755685; PMCID: PMC4819863.
      View in: PubMed, PubMed Central
    23. Mitsui Y, Chang I, Fukuhara S, Hiraki M, Arichi N, Yasumoto H, Hirata H, Yamamura S, Shahryari V, Deng G, Wong DK, Majid S, Shiina H, Dahiya R, Tanaka Y. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. BMC Cancer. 2015 Dec 01; 15:942. PMID: 26626260; PMCID: PMC4665921.
      View in: PubMed, PubMed Central
    24. Bucay N, Shahryari V, Majid S, Yamamura S, Mitsui Y, Tabatabai ZL, Greene K, Deng G, Dahiya R, Tanaka Y, Saini S. miRNA Expression Analyses in Prostate Cancer Clinical Tissues. J Vis Exp. 2015 Sep 08; (103). PMID: 26382040; PMCID: PMC4692597.
      View in: PubMed, PubMed Central
    25. Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Lau YF, Dahiya R, Tanaka Y. Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells. Oncotarget. 2015 Jun 30; 6(18):16341-51. PMID: 26036629; PMCID: PMC4599273.
      View in: PubMed, PubMed Central
    26. Mitsui Y, Hirata H, Arichi N, Hiraki M, Yasumoto H, Chang I, Fukuhara S, Yamamura S, Shahryari V, Deng G, Saini S, Majid S, Dahiya R, Tanaka Y, Shiina H. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways. Oncotarget. 2015 Apr 20; 6(11):9577-91. PMID: 25797254; PMCID: PMC4496240.
      View in: PubMed, PubMed Central
    27. Chang I, Mitsui Y, Fukuhara S, Gill A, Wong DK, Yamamura S, Shahryari V, Tabatabai ZL, Dahiya R, Shin DM, Tanaka Y. Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma. Oncotarget. 2015 Apr 10; 6(10):7774-87. PMID: 25860934; PMCID: PMC4480715.
      View in: PubMed, PubMed Central
    28. Arichi N, Mitsui Y, Hiraki M, Nakamura S, Hiraoka T, Sumura M, Hirata H, Tanaka Y, Dahiya R, Yasumoto H, Shiina H. Versican is a potential therapeutic target in docetaxel-resistant prostate cancer. Oncoscience. 2015; 2(2):193-204. PMID: 25859560; PMCID: PMC4381710.
      View in: PubMed, PubMed Central
    29. Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Hirata H, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Dahiya R, Tanaka Y. DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. Oncotarget. 2014 Nov 30; 5(22):11297-307. PMID: 25526032; PMCID: PMC4294331.
      View in: PubMed, PubMed Central
    30. Chang I, Fukuhara S, Wong DK, Gill A, Mitsui Y, Majid S, Saini S, Yamamura S, Chiyomaru T, Hirata H, Ueno K, Arora S, Shahryari V, Deng G, Tabatabai ZL, Greene KL, Shin DM, Enokida H, Shiina H, Nonomura N, Dahiya R, Tanaka Y. Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumour Biol. 2014 Oct; 35(10):10223-30. PMID: 25027399.
      View in: PubMed
    31. Saini S, Majid S, Shahryari V, Tabatabai ZL, Arora S, Yamamura S, Tanaka Y, Dahiya R, Deng G. Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer. Mol Cancer Ther. 2014 Jul; 13(7):1952-63. PMID: 24817628; PMCID: PMC4351861.
      View in: PubMed, PubMed Central
    32. Mitsui Y, Yasumoto H, Nagami T, Hiraki M, Arichi N, Ishikawa N, Araki A, Maruyama R, Tanaka Y, Dahiya R, Shiina H. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor. Oncotarget. 2014 Apr 30; 5(8):2198-207. PMID: 24755523; PMCID: PMC4039156.
      View in: PubMed, PubMed Central
    33. Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, Dahiya R, Yamamura S. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem. 2014 May 02; 289(18):12550-65. PMID: 24616104; PMCID: PMC4007447.
      View in: PubMed, PubMed Central
    34. Onoyama M, Kitadai Y, Tanaka Y, Yuge R, Shinagawa K, Tanaka S, Yasui W, Chayama K. Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer. Neoplasia. 2013 Dec; 15(12):1391-9. PMID: 24403861; PMCID: PMC3884530.
      View in: PubMed, PubMed Central
    35. Arora S, Saini S, Fukuhara S, Majid S, Shahryari V, Yamamura S, Chiyomaru T, Deng G, Tanaka Y, Dahiya R. MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases. PLoS One. 2013; 8(11):e78023. PMID: 24223753; PMCID: PMC3815229.
      View in: PubMed, PubMed Central
    36. Chiyomaru T, Yamamura S, Fukuhara S, Yoshino H, Kinoshita T, Majid S, Saini S, Chang I, Tanaka Y, Enokida H, Seki N, Nakagawa M, Dahiya R. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS One. 2013; 8(8):e70372. PMID: 23936419; PMCID: PMC3731248.
      View in: PubMed, PubMed Central
    37. Majid S, Dar AA, Saini S, Deng G, Chang I, Greene K, Tanaka Y, Dahiya R, Yamamura S. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One. 2013; 8(7):e67686. PMID: 23844063; PMCID: PMC3699593.
      View in: PubMed, PubMed Central
    38. Chang I, Majid S, Saini S, Zaman MS, Yamamura S, Chiyomaru T, Shahryari V, Fukuhara S, Deng G, Dahiya R, Tanaka Y. Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells. Mol Cancer Ther. 2013 Jun; 12(6):1049-59. PMID: 23580416.
      View in: PubMed
    39. Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One. 2013; 8(3):e58929. PMID: 23554959.
      View in: PubMed
    40. Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One. 2013; 8(1):e55502. PMID: 23383207; PMCID: PMC3559583.
      View in: PubMed, PubMed Central
    41. Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One. 2012; 7(11):e51056. PMID: 23226455; PMCID: PMC3511415.
      View in: PubMed, PubMed Central
    42. Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S, Majid S, Fukuhara S, Chang I, Arora S, Hirata H, Ueno K, Singh K, Tanaka Y, Dahiya R. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One. 2012; 7(11):e50203. PMID: 23189187; PMCID: PMC3506541.
      View in: PubMed, PubMed Central
    43. Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Tanaka Y, Chiyomaru T, Deng G, Dahiya R. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res. 2013 Jan 01; 19(1):73-84. PMID: 23147995; PMCID: PMC3910324.
      View in: PubMed, PubMed Central
    44. Majid S, Dar AA, Saini S, Arora S, Shahryari V, Zaman MS, Chang I, Yamamura S, Tanaka Y, Deng G, Dahiya R. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res. 2012 Dec 15; 72(24):6435-46. PMID: 23074286; PMCID: PMC3940348.
      View in: PubMed, PubMed Central
    45. Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Chiyomaru T, Fukuhara S, Tanaka Y, Deng G, Tabatabai ZL, Dahiya R. MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One. 2012; 7(10):e46743. PMID: 23056431; PMCID: PMC3464246.
      View in: PubMed, PubMed Central
    46. Chiyomaru T, Yamamura S, Zaman MS, Majid S, Deng G, Shahryari V, Saini S, Hirata H, Ueno K, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Nakagawa M, Dahiya R. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS One. 2012; 7(8):e43812. PMID: 22928040; PMCID: PMC3426544.
      View in: PubMed, PubMed Central
    47. Takashima T, Iwakiri R, Sakata Y, Yamaguchi D, Tsuruoka N, Akutagawa K, Komatsu-Tanaka M, Higuchi T, Tanaka Y, Shimoda R, Sakata H, Kawakubo M, Oda Y, Fujimoto K. Endoscopic reflux esophagitis and Helicobacter pylori infection in young healthy Japanese volunteers. Digestion. 2012; 86(1):55-8. PMID: 22722701.
      View in: PubMed
    48. Saini S, Majid S, Shahryari V, Arora S, Yamamura S, Chang I, Zaman MS, Deng G, Tanaka Y, Dahiya R. miRNA-708 control of CD44(+) prostate cancer-initiating cells. Cancer Res. 2012 Jul 15; 72(14):3618-30. PMID: 22552290.
      View in: PubMed
    49. Onodera H, Oshio K, Uchida M, Tanaka Y, Hashimoto T. Analysis of intracranial pressure pulse waveform and brain capillary morphology in type 2 diabetes mellitus rats. Brain Res. 2012 Jun 15; 1460:73-7. PMID: 22583857.
      View in: PubMed
    50. Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, Majid S, Chang I, Hirata H, Ueno K, Yamamura S, Singh K, Tanaka Y, Tabatabai ZL, Dahiya R. Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One. 2012; 7(2):e31060. PMID: 22347428; PMCID: PMC3275568.
      View in: PubMed, PubMed Central
    51. Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Chang I, Tanaka Y, Gupta A, Dahiya R. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis. 2012 Feb; 33(2):294-300. PMID: 22159222; PMCID: PMC3271269.
      View in: PubMed, PubMed Central
    52. Chang I, Liu J, Majid S, Saini S, Zaman MS, Yamamura S, Shahryari V, Chiyomaru T, Deng G, Dahiya R, Tanaka Y. Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway. Carcinogenesis. 2012 Feb; 33(2):420-6. PMID: 22159223.
      View in: PubMed
    53. Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y, Dahiya R. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res. 2011 Oct 01; 71(19):6208-19. PMID: 21852381; PMCID: PMC3940359.
      View in: PubMed, PubMed Central
    54. Suh SO, Chen Y, Zaman MS, Hirata H, Yamamura S, Shahryari V, Liu J, Tabatabai ZL, Kakar S, Deng G, Tanaka Y, Dahiya R. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis. 2011 May; 32(5):772-8. PMID: 21349819; PMCID: PMC3086703.
      View in: PubMed, PubMed Central
    55. Majid S, Saini S, Dar AA, Hirata H, Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, Chang I, Deng G, Dahiya R. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res. 2011 Apr 01; 71(7):2611-21. PMID: 21330408; PMCID: PMC3940352.
      View in: PubMed, PubMed Central
    56. Kawakami K, Yamamura S, Hirata H, Ueno K, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R. Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer. Int J Cancer. 2011 Feb 01; 128(3):541-50. PMID: 20340127; PMCID: PMC3940353.
      View in: PubMed, PubMed Central
    57. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clin Cancer Res. 2011 Aug 15; 17(16):5287-98. PMID: 21159887.
      View in: PubMed
    58. Chen Y, Zaman MS, Deng G, Majid S, Saini S, Liu J, Tanaka Y, Dahiya R. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila). 2011 Jan; 4(1):76-86. PMID: 21071579; PMCID: PMC3894108.
      View in: PubMed, PubMed Central
    59. Majid S, Dar AA, Saini S, Yamamura S, Hirata H, Tanaka Y, Deng G, Dahiya R. MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer. 2010 Dec 15; 116(24):5637-49. PMID: 20737563; PMCID: PMC3940365.
      View in: PubMed, PubMed Central
    60. Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, Zaman MS, Hirata H, Yamamura S, Ueno K, Tanaka Y, Dahiya R. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res. 2010 Apr 01; 70(7):2809-18. PMID: 20332239.
      View in: PubMed
    61. Kodama K, Goto T, Sato A, Sakai K, Tanaka Y, Hongo K. Standard and limitation of intraoperative monitoring of the visual evoked potential. Acta Neurochir (Wien). 2010 Apr; 152(4):643-8. PMID: 20127123.
      View in: PubMed
    62. Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, Tanaka Y, Dahiya AV, Dahiya R. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer. 2010 Jan 01; 116(1):66-76. PMID: 19885928; PMCID: PMC3954042.
      View in: PubMed, PubMed Central
    63. Kawakami K, Hirata H, Yamamura S, Kikuno N, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Cancer Res. 2009 Nov 15; 69(22):8603-10. PMID: 19887605.
      View in: PubMed
    64. Tanaka Y, Zaman MS, Majid S, Liu J, Kawakami K, Shiina H, Tokizane T, Dahiya AV, Sen S, Nakajima K. Polymorphisms of MLH1 in benign prostatic hyperplasia and sporadic prostate cancer. Biochem Biophys Res Commun. 2009 Jun 12; 383(4):440-4. PMID: 19364498.
      View in: PubMed
    65. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009 Apr; 30(4):662-70. PMID: 19221000; PMCID: PMC2664457.
      View in: PubMed, PubMed Central
    66. Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer. 2008 Aug 01; 123(3):535-42. PMID: 18404682.
      View in: PubMed
    67. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Majid S, Igawa M, Dahiya R. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer. 2008 Aug 01; 123(3):552-60. PMID: 18431742.
      View in: PubMed
    68. Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, Kawamoto K, Hirata H, Li LC, Zhao H, Okino ST, Place RF, Pookot D, Dahiya R. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 2008 Apr 15; 68(8):2736-44. PMID: 18413741.
      View in: PubMed
    69. Hirata H, Hinoda Y, Kawamoto K, Kikuno N, Suehiro Y, Okayama N, Tanaka Y, Dahiya R. Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer. J Urol. 2008 May; 179(5):2020-4. PMID: 18355840; PMCID: PMC3940351.
      View in: PubMed, PubMed Central
    70. Sakai K, Hongo K, Tanaka Y, Nakayama J. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis. Brain Tumor Pathol. 2007; 24(2):57-62. PMID: 18095132.
      View in: PubMed
    71. Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Dahiya AV, Suehiro Y, Tanaka Y, Dahiya R. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res. 2007 Sep 01; 13(17):5056-62. PMID: 17785557.
      View in: PubMed
    72. Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clin Cancer Res. 2007 Jul 15; 13(14):4123-9. PMID: 17634539.
      View in: PubMed
    73. Tanaka Y, Wood LA, Cooney RV. Enhancement of intracellular gamma-tocopherol levels in cytokine-stimulated C3H 10T1/2 fibroblasts: relation to NO synthesis, isoprostane formation, and tocopherol oxidation. BMC Chem Biol. 2007 Jul 03; 7:2. PMID: 17608946; PMCID: PMC1931582.
      View in: PubMed, PubMed Central
    74. Kawamoto K, Okino ST, Place RF, Urakami S, Hirata H, Kikuno N, Kawakami T, Tanaka Y, Pookot D, Chen Z, Majid S, Enokida H, Nakagawa M, Dahiya R. Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer. Clin Cancer Res. 2007 May 01; 13(9):2541-8. PMID: 17473182.
      View in: PubMed
    75. Tanaka Y, Hirata H, Chen Z, Kikuno N, Kawamoto K, Majid S, Tokizane T, Urakami S, Shiina H, Nakajima K, Dhir R, Dahiya R. Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer. Cancer Epidemiol Biomarkers Prev. 2007 Jan; 16(1):92-7. PMID: 17220335.
      View in: PubMed
    76. Hirata H, Hinoda Y, Tanaka Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Majid S, Vejdani K, Dahiya R. Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer. 2007 Jan; 43(2):231-7. PMID: 17196815.
      View in: PubMed
    77. Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res. 2006 Dec 01; 12(23):6989-97. PMID: 17145819.
      View in: PubMed
    78. Uchiyama A, Mukai M, Fujiwara Y, Kobayashi S, Kawai N, Murofushi H, Inoue M, Enoki S, Tanaka Y, Niki T, Kobayashi T, Tigyi G, Murakami-Murofushi K. Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid. Biochim Biophys Acta. 2007 Jan; 1771(1):103-12. PMID: 17123862; PMCID: PMC3446789.
      View in: PubMed, PubMed Central
    79. Pookot D, Li LC, Tabatabai ZL, Tanaka Y, Greene KL, Dahiya R. The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol. 2006 Aug; 176(2):793-6. PMID: 16813949.
      View in: PubMed
    80. Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2109-16. PMID: 16609023.
      View in: PubMed
    81. Hirata H, Hinoda Y, Matsuyama H, Tanaka Y, Okayama N, Suehiro Y, Zhao H, Urakami S, Kawamoto K, Kawakami T, Igawa M, Naito K, Dahiya R. Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem Biophys Res Commun. 2006 Apr 21; 342(4):1058-62. PMID: 16510122.
      View in: PubMed
    82. Tanaka Y, Sasaki M, Shiina H, Tokizane T, Deguchi M, Hirata H, Hinoda Y, Okayama N, Suehiro Y, Urakami S, Kawakami T, Kaneuchi M, Pookot D, Igawa M, Okuyama A, Ishii N, Dahiya R. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006 Feb; 15(2):238-44. PMID: 16492910.
      View in: PubMed
    83. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res. 2006 Jan 15; 12(2):383-91. PMID: 16428476.
      View in: PubMed
    84. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Yamada H, Yamamoto R, Sakuragi N, Enokida H, Verma M, Dahiya R. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer. 2005 Nov 01; 104(9):1924-30. PMID: 16134181.
      View in: PubMed
    85. Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, Nonomura N, Okuyama A, Dahiya R. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res. 2005 Aug 15; 11(16):5793-801. PMID: 16115918.
      View in: PubMed
    86. Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer. 2005 Jul 01; 104(1):44-52. PMID: 15895377.
      View in: PubMed
    87. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Enokida H, Tsujimura A, Matsumiya K, Okuyama A, Dahiya R. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol. 2005 Jan; 173(1):318-23. PMID: 15592104.
      View in: PubMed
    88. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Verma M, Ebina Y, Nomura E, Yamamoto R, Sakuragi N, Dahiya R. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer. Biochem Biophys Res Commun. 2004 Apr 16; 316(4):1156-62. PMID: 15044106.
      View in: PubMed
    89. Sasaki M, Tanaka Y, Okino ST, Nomoto M, Yonezawa S, Nakagawa M, Fujimoto S, Sakuragi N, Dahiya R. Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer. Clin Cancer Res. 2004 Mar 15; 10(6):2015-9. PMID: 15041720.
      View in: PubMed
    90. Kaneuchi M, Sasaki M, Tanaka Y, Yamamoto R, Sakuragi N, Dahiya R. Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF. Int J Oncol. 2003 Oct; 23(4):1167-72. PMID: 12964000.
      View in: PubMed
    91. Iwashita T, Tada T, Zhan H, Tanaka Y, Hongo K. Harvesting blood stem cells from cranial bone at craniotomy--a preliminary study. J Neurooncol. 2003 Sep; 64(3):265-70. PMID: 14558603.
      View in: PubMed
    92. Sasaki M, Tanaka Y, Sakuragi N, Dahiya R. Six polymorphisms on estrogen receptor 1 gene in Japanese, American and German populations. Eur J Clin Pharmacol. 2003 Sep; 59(5-6):389-93. PMID: 12923601.
      View in: PubMed
    93. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R. Polymorphisms of estrogen receptor alpha in prostate cancer. Mol Carcinog. 2003 Aug; 37(4):202-8. PMID: 12891629.
      View in: PubMed
    94. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res. 2003 Jul 15; 63(14):3913-8. PMID: 12873984.
      View in: PubMed
    95. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Tsujimura A, Matsumiya K, Okuyama A, Dahiya R. Diabetes induced erectile dysfunction and apoptosis in penile crura are recovered by insulin treatment in rats. J Urol. 2003 Jul; 170(1):291-7. PMID: 12796708.
      View in: PubMed
    96. Tanaka Y, Kobayashi S, Hongo K, Tada T, Sato A, Takasuna H. Clinical and neuroimaging characteristics of hydrocephalus associated with vestibular schwannoma. J Neurosurg. 2003 Jun; 98(6):1188-93. PMID: 12816262.
      View in: PubMed
    97. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. Alleles of polymorphic sites that correspond to hyperactive variants of CYP1B1 protein are significantly less frequent in Japanese as compared to American and German populations. Hum Mutat. 2003 Jun; 21(6):652. PMID: 14961553.
      View in: PubMed
    98. Sasaki M, Kaneuchi M, Fujimoto S, Tanaka Y, Dahiya R. Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers. Mol Cell Endocrinol. 2003 Apr 28; 202(1-2):201-7. PMID: 12770752.
      View in: PubMed
    99. Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Estrogen receptor alpha polymorphisms and renal cell carcinoma--a possible risk. Mol Cell Endocrinol. 2003 Apr 28; 202(1-2):109-16. PMID: 12770739.
      View in: PubMed
    100. Sasaki M, Kaneuchi M, Fujimoto S, Tanaka Y, Dahiya R. CYP1B1 gene in endometrial cancer. Mol Cell Endocrinol. 2003 Apr 28; 202(1-2):171-6. PMID: 12770747.
      View in: PubMed
    101. Kaneuchi M, Sasaki M, Tanaka Y, Sakuragi N, Fujimoto S, Dahiya R. Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1. Int J Oncol. 2003 Jan; 22(1):159-64. PMID: 12469199.
      View in: PubMed
    102. Yamanaka M, Shirai M, Shiina H, Shirai M, Tanaka Y, Fujime M, Okuyama A, Dahiya R. Loss of anti-apoptotic genes in aging rat crura. J Urol. 2002 Nov; 168(5):2296-300. PMID: 12394778.
      View in: PubMed
    103. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. Polymorphisms of estrogen receptor alpha gene in endometrial cancer. Biochem Biophys Res Commun. 2002 Sep 27; 297(3):558-64. PMID: 12270131.
      View in: PubMed
    104. Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Single nucleotide polymorphisms of estrogen receptor alpha in human renal cell carcinoma. Biochem Biophys Res Commun. 2002 Sep 06; 296(5):1200-6. PMID: 12207901.
      View in: PubMed
    105. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R. Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer. Biochem Biophys Res Commun. 2002 Aug 30; 296(4):820-6. PMID: 12200121.
      View in: PubMed
    106. Zhao H, Patra A, Tanaka Y, Li LC, Dahiya R. Transforming growth factor-beta(s) and their receptors in aging rat prostate. Biochem Biophys Res Commun. 2002 Jun 07; 294(2):464-9. PMID: 12051734.
      View in: PubMed
    107. Nakazato F, Tada T, Sekiguchi Y, Murakami K, Yanagisawa S, Tanaka Y, Hongo K. Disturbed spatial learning of rats after intraventricular administration of transforming growth factor-beta 1. Neurol Med Chir (Tokyo). 2002 Apr; 42(4):151-6; discussion 157. PMID: 12013666.
      View in: PubMed
    108. Zhao H, Patra A, Yeh CC, Tanaka Y, Oh BR, Dahiya R. Effects of aging on growth factors gene and protein expression in the dorsal and ventral lobes of rat prostate. Biochem Biophys Res Commun. 2002 Mar 29; 292(2):482-91. PMID: 11906188.
      View in: PubMed
    109. Sasaki M, Tanaka Y, Perinchery G, Dharia A, Kotcherguina I, Fujimoto Si, Dahiya R. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst. 2002 Mar 06; 94(5):384-90. PMID: 11880477.
      View in: PubMed
    110. Franke AA, Custer LJ, Cooney RV, Tanaka Y, Xu M, Dashwood RH. Inhibition of colonic aberrant crypt formation by the dietary flavonoids (+)-catechin and hesperidin. Adv Exp Med Biol. 2002; 505:123-33. PMID: 12083456.
      View in: PubMed
    Yuichiro's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (468) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (11) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    ↑